Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Digestion|January 1, 1996
The use of new somatostatin analogues, lanreotide and octastatin, in neuroendocrine gastro-intestinal tumoursB Eriksson, E T Janson, N D Bax, et al.Neuroendocrinology|February 21, 2008
Treatment with combined streptozotocin and liposomal doxorubicin in metastatic endocrine pancreatic tumorsMarie-Louise H Fjallskog, Eva T Janson, Ursula G Falkmer, et al.Cancer|September 26, 2001
Treatment with cisplatin and etoposide in patients with neuroendocrine tumorsM L Fjällskog, D P Granberg, S L Welin, et al.The Journal of Clinical Endocrinology and Metabolism|August 5, 2004
Malignant gastric ghrelinoma with hyperghrelinemiaApostolos V Tsolakis, Guida M Portela-Gomes, Mats Stridsberg, et al.European Journal of Endocrinology|July 14, 2004
High-dose treatment with a long-acting somatostatin analogue in patients with advanced midgut carcinoid tumoursStaffan V Welin, Eva Tiensuu Janson, Anders Sundin, et al.Endocrine Connections|March 14, 2019
NETest liquid biopsy is diagnostic of small intestine and pancreatic neuroendocrine tumors and correlates with imagingAnna Malczewska, Magdalena Witkowska, Karolina Makulik, et al.Endocrine-Related Cancer|July 19, 2012
Pasireotide (SOM230) shows efficacy and tolerability in the treatment of patients with advanced neuroendocrine tumors refractory or resistant to octreotide LAR: results from a phase II studyLarry K Kvols, Kjell E Oberg, Thomas M O'Dorisio, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Efficacy and safety of prolonged-release lanreotide in patients with gastrointestinal neuroendocrine tumors and hormone-related symptomsA N Wymenga, B Eriksson, P I Salmela, et al.Pageof 3